GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BNC Korea Co Ltd (XKRX:256840) » Definitions » Equity-to-Asset

BNC Korea Co (XKRX:256840) Equity-to-Asset : 0.87 (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is BNC Korea Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. BNC Korea Co's Total Stockholders Equity for the quarter that ended in Jun. 2024 was ₩212,540 Mil. BNC Korea Co's Total Assets for the quarter that ended in Jun. 2024 was ₩244,930 Mil. Therefore, BNC Korea Co's Equity to Asset Ratio for the quarter that ended in Jun. 2024 was 0.87.

The historical rank and industry rank for BNC Korea Co's Equity-to-Asset or its related term are showing as below:

XKRX:256840' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.28   Med: 0.86   Max: 0.9
Current: 0.87

During the past 8 years, the highest Equity to Asset Ratio of BNC Korea Co was 0.90. The lowest was 0.28. And the median was 0.86.

XKRX:256840's Equity-to-Asset is ranked better than
90.53% of 1066 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs XKRX:256840: 0.87

BNC Korea Co Equity-to-Asset Historical Data

The historical data trend for BNC Korea Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BNC Korea Co Equity-to-Asset Chart

BNC Korea Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial 0.56 0.55 0.38 0.79 0.89

BNC Korea Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.88 0.89 0.89 0.89 0.87

Competitive Comparison of BNC Korea Co's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, BNC Korea Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BNC Korea Co's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BNC Korea Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where BNC Korea Co's Equity-to-Asset falls into.



BNC Korea Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

BNC Korea Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=209531.906/236152.384
=0.89

BNC Korea Co's Equity to Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

Equity to Asset (Q: Jun. 2024 )=Total Stockholders Equity/Total Assets
=212539.528/244929.691
=0.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BNC Korea Co  (XKRX:256840) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


BNC Korea Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of BNC Korea Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


BNC Korea Co Business Description

Traded in Other Exchanges
N/A
Address
62 Seongseogongdan-ro 11-gil, Dalseo-gu, No 405, Structure 1, Daegu Techno Park Venture Factory, Daegu, KOR, 42713
BNC Korea Co Ltd is a Korean healthcare company. The company is engaged in manufacturing medicinal chemicals, antibiotics, and biological products. IIts product offering includes cutegel, cutegel lidocaine, FLORE lidocaine, ChungA-an, cutegel-M under the HA filler product line. While it also offers Skin booster filler, hibarry, gentaQ, and I.st products.

BNC Korea Co Headlines

No Headlines